Applying the Carrot-and-Stick Approach to Biotech.
Year: 2006
Type: article
Abstract: Long the cornerstone of formulary building, preferred-product designations are emerging within classes of biotech therapies. Still in its infancy, this phenomenon is a logical if not unexpected step, but choosing a preferred specialty drug is far more complicated than doing the same for traditional therapies.
Source: Europe PMC (PubMed Central)
Author: John Carroll
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W4201497